Royal Bank of Canada’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,000
Closed -$51K 7046
2019
Q3
$51K Hold
9,000
﹤0.01% 5114
2019
Q2
$69K Buy
+9,000
New +$48.5K ﹤0.01% 5081
2016
Q2
Sell
-70,630
Closed -$2.37M 6483
2016
Q1
$2.37M Buy
70,630
+20,180
+40% +$635K ﹤0.01% 2326
2015
Q4
$1.51M Hold
50,450
﹤0.01% 2775
2015
Q3
$1.59M Buy
+50,450
New +$2.46M ﹤0.01% 2455

Other funds holding PGEN

Royal Bank of Canada's PGEN Position: Q1 2026 in Review

Royal Bank of Canada increased its Precigen (PGEN) stake by 103% in Q1 2026, buying an estimated $22.3K and bringing the position to 10,714 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #5586.

Royal Bank of Canada first reported a position in PGEN in Q3 2013 and has held it in 46 quarters since. The position peaked at $1.72M in Q3 2015. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Royal Bank of Canada held 10,714 shares of Precigen worth $41K as of Q1 2026.
  • Royal Bank of Canada bought 5,426 Precigen shares in Q1 2026, an estimated $22.3K.
  • Precigen made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5586 holding.
  • Royal Bank of Canada first reported a position in Precigen in Q3 2013 and has held it in 46 quarters since.
  • Royal Bank of Canada's Precigen position peaked at $1.72M in Q3 2015.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.